An advocate for your vision

An advocate for your vision

Dr. Rehan Hussain is a highly regarded ophthalmologist specializing in the advanced management of vitreoretinal surgery. With a dedication to utilizing the latest in medical technology, Dr. Hussain ensures his patients receive world-class, personalized care tailored to their specific needs.

Slide 1

Experts in Retina Care

At Retina Specialist of Illinois (RSI), we are dedicated to the advanced medical and surgical management of vitreoretinal and ocular diseases. We treat a wide range of conditions, including age-related macular degeneration, diabetic retinopathy, retinal detachments, vascular disorders, and ocular malignancies.

Slide 1

Dr Rehan Hussain is a leading Illinois eye specialist

Currently affiliated with :
◉ Retina Health Institute
◉ Simpson Eye Physicians & Surgeons
◉ Gailey Eye Clinic

Slide 1

RSI Software - AI in Opthomology

Retina Specialist of Illinois is at the forefront of innovation, developing cutting-edge Artificial Intelligence (AI) solutions to assist ophthalmologists in diagnosing and treating retinal and ocular diseases.

Slide 1

How do I know I need Vitreoretinal eye surgery?

previous arrow
next arrow

Excellence in patient care

Dr. Hussain delivers exceptional care that is respectful and responsive to individual patients.

An advocate for your vision

Dr. Hussain is passionate to improve the lives of all patients with vitreoretinal disorders and to promote retina education and awareness

Accomplished

Dr. Hussain is board certified by the American Board of Ophthalmology and has authored over 80 publications in peer-reviewed journals and textbooks pertaining to ophthalmology and retinal disease.

About

Why Dr Rehan Hussain?

Dr. Hussain is a born and raised Chicagoland-native. He completed his undergraduate and medical education in an accelerated 7-year program at The George Washington University in Washington, DC. He was honored with inductions into both the Phi Beta Kappa Society and Alpha Omega Alpha Honor Medical Society while there.

Dr. Hussain completed his residency training at the Indiana University School of Medicine, serving as the Chief Resident his final year. He completed two fellowships in ophthalmic pathology and vitreoretinal surgery at the University of Miami’s Bascom Palmer Eye Institute, which has been recognized as the nation’s #1 eye hospital over the past three decades.

Dr. Hussain provides personalized care in a gentle and kind manner

AI-Eye-Telligence Software
(Revolutionizing Healthcare with Ophthalmology Solutions)

Our in development AI-Eye-Telligence is a software as a medical device (SaMD) that uses clinically validated AI algorithms to analyse digital retinal images.

This technology can detect early features of glaucoma, diabetic retinopathy (DR), neovascular age-related macular degeneration (nAMD), as well as screening for cardiovascular disease (CVD) risks. Its AI sets new benchmarks in affordable disease screening tools, while its evidence-based reporting empowers clinicians to make informed decisions with speed, accuracy, and confidence.

Accreditation and Credentials

Dr. Hussain is board certified by the American Board of Ophthalmology. He is a member of the American Academy of Ophthalmology, American Society of Retina Specialists, and the Vit-Buckle Society. He has presented retina-related research and surgical videos at numerous national meetings. He has authored over 80 publications in peer-reviewed journals and textbooks pertaining to ophthalmology and retinal disease.

Discover What Our
Patients Have To Say

We pride ourselves on providing exceptional care to every patient we serve. Don’t just take our word for it – hear directly from those who have experienced our dedication firsthand. Read the testimonials below to learn about the experiences of our valued patients and their journeys to improved eye health and vision.

What Our Clients Say About Us

Publications

News & Announcements

Tyrosine kinase inhibitors (TKIs) serve to inhibit the phosphorylation cascade that usually leads to abnormal processes such as vascular leakage and tumorigenesis. Within retinal diseases specifically,

2024 Dec 23

EYP-1901 (Duravyu) has demonstrated promising outcomes in Phases I and II clinical trials for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)/diabetic retinopathy.

 2024 Oct 3

Purpose: The clinical practice visual acuity (VA) outcomes of anti-VEGF therapy for up to 5 years were assessed in patients with neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), 

2022 Apr 2

Our Affiliated Clinics

2320 N Huntington Dr,
Algonquin IL 60102
&
1075 Featherstone Rd,
Suite 10, Rockford IL 61107

2121 Marquette Rd, Peru, IL 61354
&
4100 Veterans Dr, Ottawa IL 61350

650 Spring Hill Ring Rd, suite 2020, West Dundee, IL 60118

Retina Specialist of Illinois
(AI Research Center and Administrative Office)

55 Witt Rd, South Barrington, IL 60010